Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
An announcement from ConvaTec ( (GB:CTEC) ) is now available.
ConvaTec Group PLC has announced the purchase of 1,472,554 ordinary shares as part of its $300 million share buyback program, initiated on August 20, 2025. The shares, bought at a volume-weighted average price of 236.30 pence, will be held in treasury, reflecting the company’s strategy to enhance shareholder value and optimize its capital structure.
The most recent analyst rating on (GB:CTEC) stock is a Buy with a £315.00 price target. To see the full list of analyst forecasts on ConvaTec stock, see the GB:CTEC Stock Forecast page.
Spark’s Take on GB:CTEC Stock
According to Spark, TipRanks’ AI Analyst, GB:CTEC is a Neutral.
ConvaTec’s strong financial performance and strategic positioning are tempered by bearish technical indicators and a high valuation. Regulatory challenges may pose risks, but the company’s innovation pipeline and operational strength support a moderately positive outlook.
To see Spark’s full report on GB:CTEC stock, click here.
More about ConvaTec
ConvaTec Group PLC is a company operating in the medical products and technologies industry, focusing on wound care, ostomy care, continence and critical care, and infusion devices. The company serves healthcare providers and patients globally, aiming to improve the lives of people with chronic conditions.
Average Trading Volume: 7,998,291
Technical Sentiment Signal: Buy
Current Market Cap: £4.96B
For a thorough assessment of CTEC stock, go to TipRanks’ Stock Analysis page.